On Wednesday, Shares of Time Warner Inc (NYSE:TWX), added 1.71% and closed at $79.91 in the last trading session. The last trading range of the stock ranges between $78.54 and $80.44. The company’s Market capitalization is $61.54 Billion with the total Outstanding Shares of 777.84 million. During the 52-week trading session the minimum price at which share price traded, registered at $55.53 and reached to max level of $81.33. Time Warner Inc. Chief Financial Officer Howard Averill recently declared that Jessica Holscott, has been designated to lead Time Warner’s Shareholder Relations group and serve as the company’s principal day-to-day contact with the investment community. Ms. Holscott joined Time Warner in March of this year to work closely with and eventually succeed Mike Kopelman, who served as head of the IR group for the past three years. Mr. Kopelman is joining Home Box Office as Senior Vice President, Finance – Planned Planning.
In making the declarement Mr. Averill said: “With nearly two decades of experience under her belt and extensive knowledge of financial operations, Jessica is the right person to lead our shareholder relations efforts. In her previous role at Delphi, Institutional Shareholder ranked Jessica and her group at Delphi as being the top Shareholder Relations officer and Shareholder Relations team respectively in their industry. And in the months since she has joined Time Warner, she has already become an integral part of the Company’s corporate administration team.”
Mast Therapeutics Inc (NYSEMKT: MSTX), dropped -4.01% and closed at $0.0910 in the last trading session. The last trading range of the stock ranges between $0.09 and $0.09. The company’s Market capitalization is $19.07 million with the total Outstanding Shares of 211.82 million. During the 52-week trading session the minimum price at which share price traded, registered at $0.09 and reached to max level of $0.71. Mast Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for serious or life-threatening diseases with noteworthyunmet needs. The companys lead product candidate is MST-188 (vepoloxamer), an injection used for the treatment of sickle cell disease, arterial disease, and heart failure. It also develops AIR001, a sodium nitrite solution for intermittent inhalation via nebulizer, in addition to for the treatment of heart failure with preserved ejection fraction.
Liberty Global plc – Class C Ordinary Shares (NASDAQ:LBTYK), gained 0.79% and closed at $31.76 in the last trading session. The last trading range of the stock ranges between $25.86 and $31.81. During the 52-week trading session the minimum price at which share price traded, registered at $25.86and reached to max level of $39.11. C&W Networks, a division of Cable & Wireless Communications, (C&W), one of the leading full service communications and entertainment providers in the Caribbean and Latin American region, now part of Liberty Global (LiLAC Group), recently declared that it has expanded its reach with the integration of the recently activated, state-of-the-art Point-of-Presence (POP) node at the Jacksonville, Florida Network Access Point (NAP) known as Jax NAP.
The expansion of C&W Networks’ capacity is part of its overall strategy to deliver advanced connectivity through a wide range of interconnect options to terrestrial networks and other international carriers located in the Jax NAP facility. With the unlimited carrier access the Jax NAP provides its customers, C&W Networks will further enhance its position among the top tier players across the fast-growing region of the Caribbean, Central and South American markets.